A Novel Role of Uricosuric Agent Benzbromarone in BK Channel Activation and Reduction of Airway Smooth Muscle Contraction
- 20 January 2023
- journal article
- research article
- Published by Elsevier in Molecular Pharmacology
- Vol. 103 (4) , 241-254
Abstract
A uricosuric drug benzbromarone, widely used for treatment of gout, hyperpolarizes the membrane potential of airway smooth muscle cells, but how it works remains unknown. Here we show a novel role of benzbromarone in activation of large conductance calcium-activated K+ channels. Benzbromarone results in dose-dependent activation of macroscopic BK currents about 1.7 to 14.5 folds with an EC50 of 111 μM and shifts the voltage-dependent channel activation to a more hyperpolarizing direction about 10 to 54 mV in whole-cell patch clamp recordings. In single-channel recordings, benzbromarone decreases single BKα channel closed dwell time and increases the channel open probability. Co-expressing β1 subunit also enhances BK activation by benzbromarone with an EC50 of 67 μM and a leftward shift of G-V curve about 44 to 138 mV. Site-directed mutagenesis reveals that a motif of three amino acids 329RKK331 in the cytoplasmic linker between S6 and C-terminal RCK gating ring mediates the pharmacological activation of BK channels by benzbromarone. Further ex vivo assay shows that benzbromarone causes reduction of tracheal strip contraction. Taken together, our findings demonstrate that uricosuric benzbromarone activates BK channels through molecular mechanism of action involving the channel RKK motif of S6-RCK linker. Pharmacological activation of BK channel by benzbromarone causes reduction of tracheal strip contraction, holding a repurposing potential for asthma and pulmonary arterial hypertension or BK channelopathies. Significance Statement We describe a novel role of uricosuric agent benzbromarone in BK channel activation and relaxation of airway smooth muscle contraction. In this study, we find that benzbromarone is an activator of the large-conductance Ca2+- and voltage-activated K+ channel (BK channel) that serves numerous cellular functions including control of smooth muscle contraction. Pharmacological activation of BK channel by an FDA approved drug benzbromarone may hold repurposing potential for treatment of asthma and pulmonary arterial hypertension or BK channeopathies.Keywords
This publication has 77 references indexed in Scilit:
- Calcium-activated chloride channel TMEM16A modulates mucin secretion and airway smooth muscle contractionProceedings of the National Academy of Sciences, 2012
- Molecular mechanism of pharmacological activation of BK channelsProceedings of the National Academy of Sciences, 2012
- The steroid interaction site in transmembrane domain 2 of the large conductance, voltage- and calcium-gated potassium (BK) channel accessory β1 subunitProceedings of the National Academy of Sciences, 2011
- Ion sensing in the RCK1 domain of BK channelsProceedings of the National Academy of Sciences, 2010
- LRRC26 auxiliary protein allows BK channel activation at resting voltage without calciumNature, 2010
- Large conductance calcium-activated potassium channels affect both spontaneous firing and intracellular calcium concentration in cerebellar Purkinje neuronsNeuroscience, 2009
- The RCK2 domain of the human BK Ca channel is a calcium sensorProceedings of the National Academy of Sciences, 2008
- Calcium-sensitive potassium channelopathy in human epilepsy and paroxysmal movement disorderNature Genetics, 2005
- Cloning and Functional Characterization of Novel Large Conductance Calcium-activated Potassium Channel β Subunits, hKCNMB3 and hKCNMB4Journal of Biological Chemistry, 2000
- Paxilline Inhibition of the Alpha-subunit of the High-conductance Calcium-activated Potassium ChannelNeuropharmacology, 1996